P/87/2010
Submitted by Anonymous (not verified) on 6 February 2025 - 11:28
P/87/2010
Submission deadlines for orphan designations
Submitted by Anonymous (not verified) on 6 February 2025 - 10:52
Submission deadlines for orphan designations
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
Submitted by Anonymous (not verified) on 5 February 2025 - 16:46
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Submitted by Anonymous (not verified) on 5 February 2025 - 16:45
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
PSUSA/00002229/202404
Submitted by Anonymous (not verified) on 5 February 2025 - 15:40
PSUSA/00002229/202404
EMEA-001434-PIP01-13-M03
Submitted by Anonymous (not verified) on 5 February 2025 - 15:39
EMEA-001434-PIP01-13-M03
PSUSA/00010774/202403
Submitted by Anonymous (not verified) on 5 February 2025 - 15:35
PSUSA/00010774/202403
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Submitted by Anonymous (not verified) on 5 February 2025 - 15:22
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Date of authorisation: 09/06/2000, Revision: 42, Status: Authorised
Submitted by Anonymous (not verified) on 5 February 2025 - 15:20
Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Date of authorisation: 09/06/2000, Revision: 42, Status: Authorised
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 34, Status: Authorised
Submitted by Anonymous (not verified) on 5 February 2025 - 15:12
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 34, Status: Authorised